Metcela
株式会社メトセラ | 細胞の力を生きる力に
Tokyo, Japan · Founded 2016 · $30.7M raised
- Headquarters
- Tokyo
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- metcela.com
- Total Funding
- $30.7M
- Last Round
- $14.0M Series CJun 2022
- Rounds
- 4
About
Metcela is a Japanese biotech company focused on cell therapy and regenerative medicine research.
Summary
Metcela is a Biotech company based in Tokyo, Japan, founded in 2016. It has raised $30.7M in total across 4 rounds, most recently a $14.0M Series C round in Jun 2022. Investors include Eight Roads Ventures, F-Prime Capital and Japan Lifeline Co., Ltd..
Tech & App Stack
5 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2022
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.